Table 2 Studies focused on HIV ordered alphabetically by author's name.
| Author | Intervention | Setting | Country | Quality | Static/ dynamic model | Main CE findings |
|---|---|---|---|---|---|---|
| Bramley (2003)33 | Antenatal screening | Secondary care | New Zealand | + | Static | NZ$17 241 per life year gained (year unclear) |
| Brandeau (1992)34 | Screening women of childbearing age | Undefined | USA | + | Static | −$35 (cost saving) to −$12 132 per woman screened (1998 value) |
| Bos (2001)35 | Screening of STD clinic attendees | Primary care | the Netherlands | + | Static | €1333 to €1638 per life year gained (2000 value) |
| Gibb (1999)36 | Antenatal screening | Antenatal care | UK | + | Static | £51 258 cost per life year saved (1996/7 value) |
| Heumann (2001)37 | Referral of high risk groups to prevention services | Primary care, San Francisco | USA | + | Static | $43 765 cost per infected averted (year unclear) |
| Holtgrave et al (1993)38 | Multiple interventions delivered by entire programme (counselling, testing, referral, partner notification) | Public health centres | USA | + | Static | $ 80 per infection averted (1990 value) |
| Hughes (1996)39 | GP prescribed condoms | Primary care | UK | + | Static | £180 to £1.3m per life year gained (1993/4 value) |
| La Croix (1996)40 | Voluntary screening | Inpatients | USA | – | Static | $1391 to $47 722 net benefit (year unclear) |
| Lurie et al (1994)41 | Voluntary counselling and screening for HIV | Acute care | USA | – | Static | $16 104 cost per patient infected, $753m per health care worker infection avoided (year unclear) |
| Owens et al (1996)42 | Screening for HIV | Acute care | USA | + | Static | $44 200 to $70 000 cost per QALY (1993 value) |
| Paltiel (2005)43 | Routine screening in outpatient settings in addition to current practice of background testing or testing those with opportunistic infections | Outpatient settings | US | + | Static | $36k to $100k cost per QALY (2001 value) |
| Phillips and Fernyak (2000)44 | HIV counselling and testing | Primary care | USA | + | Static | $5300 to $23 300 cost per QALY (1999 value) |
| Pinkerton et al (1998)45 | Post‐exposure prophylaxis following sexual exposure to HIV | Setting not explicit | USA | + | Static | $6354 to $7m cost per QALY (1996 value) |
| Sanders (2005)46 | Voluntary screening with highly active antiretroviral treatment | Primary care and outpatient settings | USA | + | Static | $15 078 to $57 138 cost per QALY (2004 value) |
| Tao (1998)47 | Individual risk assessment, risk reduction counselling, referral to medical and psychosocial services, for gay and bisexual male adolescents | Community setting | USA | + | Static | $6180 cost per QALY (1994 value) |
| Toomey et al (1998)48 | Partner notification | STD clinics | USA | – | Static | $251 per index patient identified, $2200 per partner newly identified (year unclear) |
| Varghese (1999)49 | Counselling, testing, and partner notification | STD clinics | USA | + | Static | $28 025 to $31 943 per case averted (1997 value) |
| Varghese and Peterman (2001)50 | HIV counselling and testing | Prison | USA | + | Static | $34 000 per case averted (1999 value) |
| Zowall et al (1990)51 | Screening | Pre‐immigration testing | Canada | – | Static | CAN1.7m to CAN $13.7m (1988 value) |
CE, clinical evidence; GP, general practitioner; STD, sexually transmitted disease; QALY, quality adjusted life years.